Rong Li , Hongping Zhang , Qingshui Li , Guangwen Yuan , Yanjie Zhou , Rutie Yin , He Wang , Chunyan Wang , Yi Huang , Wei Wang , Xiaojian Yan , Lingying Wu , Qi Zhou
{"title":"“紫杉醇脂体与紫杉醇联合卡铂在卵巢癌一线化疗中的疗效和安全性:一项多中心、开放标签、非劣效性、随机对照试验”的勘误表[Journal of the National cancer Center 4 (2024) 135-141]","authors":"Rong Li , Hongping Zhang , Qingshui Li , Guangwen Yuan , Yanjie Zhou , Rutie Yin , He Wang , Chunyan Wang , Yi Huang , Wei Wang , Xiaojian Yan , Lingying Wu , Qi Zhou","doi":"10.1016/j.jncc.2024.11.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73987,"journal":{"name":"Journal of the National Cancer Center","volume":"5 1","pages":"Page 93"},"PeriodicalIF":7.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to ‘Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial’ [Journal of the National Cancer Center 4 (2024) 135–141]\",\"authors\":\"Rong Li , Hongping Zhang , Qingshui Li , Guangwen Yuan , Yanjie Zhou , Rutie Yin , He Wang , Chunyan Wang , Yi Huang , Wei Wang , Xiaojian Yan , Lingying Wu , Qi Zhou\",\"doi\":\"10.1016/j.jncc.2024.11.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73987,\"journal\":{\"name\":\"Journal of the National Cancer Center\",\"volume\":\"5 1\",\"pages\":\"Page 93\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the National Cancer Center\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667005424001121\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Center","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667005424001121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Corrigendum to ‘Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial’ [Journal of the National Cancer Center 4 (2024) 135–141]